Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282516 · ClinicalTrials.gov registry record · NA
Asthma In-Home Monitoring (AIM) Trial
A NA study of Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines, sponsored by Tripler Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT00282516: Completed NA study of Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines, sponsored by Tripler Army Medical Center.
NCT00282516 is a NA study of Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines that has completed, run by Tripler Army Medical Center. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00282516, a NA study of Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines, has completed, sponsored by Tripler Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits.
Conditions Studied
Interventions
- PROCEDURE In-home telemonitoring of pediatric patients with persistent asthma
Study Locations (1)
Hawaii
- Tripler Army Medical Center - Tripler AMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2003-04 |
| Est. Completion | 2004-04 |
| Phase | NA |
What the finished NCT00282516 record still lists
NCT00282516 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines appearing as the primary indexed condition, and to 1 intervention - of which In-home telemonitoring of pediatric patients with persistent asthma is the first listed.
NCT00282516 reports a single indexed study location in Hawaii.
Frequently Asked Questions
What is clinical trial NCT00282516 about?
NCT00282516 is a clinical study titled "Asthma In-Home Monitoring (AIM) Trial". OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits.
What is the current status of trial NCT00282516?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2003-04. Estimated completion is 2004-04.
What conditions does trial NCT00282516 study?
This clinical trial studies the following conditions: Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines.
What interventions are being tested in trial NCT00282516?
The interventions under investigation include: In-home telemonitoring of pediatric patients with persistent asthma (PROCEDURE).
Who is sponsoring clinical trial NCT00282516?
This trial is sponsored by Tripler Army Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00282516 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00282516's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia